Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 21;14(7):2139.
doi: 10.3390/jcm14072139.

Lights and Shadows on Artificial Intelligence in Glaucoma: Transforming Screening, Monitoring, and Prognosis

Affiliations
Review

Lights and Shadows on Artificial Intelligence in Glaucoma: Transforming Screening, Monitoring, and Prognosis

Alessio Martucci et al. J Clin Med. .

Abstract

Background/Objectives: Artificial intelligence (AI) is increasingly being integrated into medicine, including ophthalmology, owing to its strong capabilities in image recognition. Methods: This review focuses on the most recent key applications of AI in the diagnosis and management of, as well as research on, glaucoma by performing a systematic review of the latest papers in the literature. Results: In glaucoma, AI can help analyze large amounts of data from diagnostic tools, such as fundus images, optical coherence tomography scans, and visual field tests. Conclusions: AI technologies can enhance the accuracy of glaucoma diagnoses and could provide significant economic benefits by automating routine tasks, improving diagnostic accuracy, and enhancing access to care, especially in underserved areas. However, despite these promising results, challenges persist, including limited dataset size and diversity, class imbalance, the need to optimize models for early detection, and the integration of multimodal data into clinical practice. Currently, ophthalmologists are expected to continue playing a leading role in managing glaucomatous eyes and overseeing the development and validation of AI tools.

Keywords: artificial intelligence; deep learning; fundus imaging; glaucoma; machine learning; optical coherence tomography; visual field test.

PubMed Disclaimer

Conflict of interest statement

The authors declare that no competing interests exist.

Figures

Figure 1
Figure 1
Machine learning branches.
Figure 2
Figure 2
Possible applications of AI in glaucoma.

Similar articles

Cited by

References

    1. Martucci A., Nucci C. Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma. Neural Regen. Res. 2019;14:197. - PMC - PubMed
    1. Trouilloud A., Ferry E., Boucart M., Kauffmann L., Warniez A., Rouland J.F., Peyrin C. Impact of glaucoma on the spatial frequency processing of scenes in central vision. Vis. Neurosci. 2023;40:E001. - PMC - PubMed
    1. Gallo Afflitto G., Aiello F., Cesareo M., Nucci C. Primary Open Angle Glaucoma Prevalence in Europe: A Systematic Review and Meta-Analysis. J. Glaucoma. 2022;31:783–788. - PubMed
    1. Tham Y.C., Li X., Wong T.Y., Quigley H.A., Aung T., Cheng C.Y. Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040. Ophthalmology. 2014;121:2081–2090. - PubMed
    1. Steinmetz J.D., Bourne R.R.A., Briant P.S., Flaxman S.R., Taylor H.R.B., Jonas J.B., Abdoli A.A., Abrha W.A., Abualhasan A., Abu-Gharbieh E.G., et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study. Lancet Glob. Health. 2021;9:e144–e160. - PMC - PubMed

LinkOut - more resources